Naxin Yuan

Potential of curcumin and resveratrol as biochemical and biophysical modulators during lung cancer in rats

A. Malhotra, D. Liu, Bangzhi He, 2018, Drug and chemical toxicology.

TASK-1 induces gefitinib resistance by promoting cancer initiating cell formation and epithelial-mesenchymal transition in lung cancer.

Xingwen Wang, Fang Chen, Naxin Yuan, 2017, Experimental and therapeutic medicine.

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer

Y. Qu, Lingdan Lin, Naxin Yuan, 2018, Experimental and therapeutic medicine.

Aberrant expression of HIF3A in plasma of patients with non‐small cell lung cancer and its clinical significance

Yingying Chen, Naxin Yuan, Liang Wei, 2021, Journal of clinical laboratory analysis.